Some psoriasis studies you shouldn't miss

In this slideshow, we highlight some of this year's clinical advances in psoriasis and plaque psoriasis.

In this slideshow, we highlight some of this year's clinical advances in psoriasis and plaque psoriasis.

Related Videos
Experts on Plaque Psoriasis
Experts on Plaque Psoriasis
Experts on Plaque Psoriasis
Experts on Plaque Psoriasis
Experts on plaque psoriasis
Experts on Plaque Psoriasis
Experts on Plaque Psoriasis
Experts on Plaque Psoriasis
Related Content

Roflumilast Safe and Efficient for Patients with Chronic Plaque Psoriasis

March 22nd 2023

Why You Should You Be Prescribing Tapinarof for Plaque Psoriasis

September 10th 2022

Study: Risk of Psoriasis Related to BMI

December 21st 2021

Apremilast Use During COVID-19

December 21st 2021

Phase 3 Tapinarof Data Released

December 8th 2021

What to Know: Phase 3 Findings on Promising Psoriasis Pipeline

October 24th 2021

Roflumilast Safe and Efficient for Patients with Chronic Plaque Psoriasis

March 22nd 2023

Why You Should You Be Prescribing Tapinarof for Plaque Psoriasis

September 10th 2022

Study: Risk of Psoriasis Related to BMI

December 21st 2021

Apremilast Use During COVID-19

December 21st 2021

Phase 3 Tapinarof Data Released

December 8th 2021

What to Know: Phase 3 Findings on Promising Psoriasis Pipeline

October 24th 2021

Roflumilast Safe and Efficient for Patients with Chronic Plaque Psoriasis

March 22nd 2023

Why You Should You Be Prescribing Tapinarof for Plaque Psoriasis

September 10th 2022

Study: Risk of Psoriasis Related to BMI

December 21st 2021

Apremilast Use During COVID-19

December 21st 2021

Phase 3 Tapinarof Data Released

December 8th 2021

What to Know: Phase 3 Findings on Promising Psoriasis Pipeline

October 24th 2021
© 2023 MJH Life Sciences

All rights reserved.